Insiders argenx SE Nasdaq

Equities

ARGX

US04016X1019

Market Closed - Nasdaq Other stock markets 21:00:00 06/06/2024 BST			5-day change	1st Jan Change
386.8 ^USD	+0.47%		+6.80%	+1.67%

05-30	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
05-29	European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Argenx SE Appoints Dr. Brian L. Kotzin as Non-Executive Director to the Board of Directors	05-08	CI
Fed Officials Comments Awaited as Exchange-Traded Funds, Equity Futures Decline Pre-Bell Tuesday	11-28	MT
High Treasury Yields Pressure Exchange-Traded Funds, Equity Futures Premarket Thursday	02/03/23	MT
Immunology Company Argenx Appoints New COO	02/03/23	MT
Argenx Names Karen Massey as Chief Operating Officer	02/03/23	MT
Argenx Announces Planned Transition of Chief Operating Officer	02/03/23	CI
Argenx SE Appoints Steve Krognes to Board of Directors	28/02/23	CI
Argenx SE Announces Werner Lanthaler Will Resign as Non-Executive Director of Board and Chair of Audit and Compliance Committee	16/01/23	CI
Argenx SE Appoints Ana Cespedes as Non-Executive Director to Its Board of Directors	12/12/22	CI
Argenx SE Announces the Retirement of Hans De Haard as Chief Scientific Officer	27/10/22	CI
Argenx Appoints Camilla Sylvest to Board of Directors	08/09/22	CI
Argenx SE Announces Board Changes	03/03/22	CI
Argenx : Names Pfizer Executive as CFO	01/06/21	MT
Argenx SE Announces Board Changes	11/05/21	CI
Molecular Partners AG Announces Executive Changes	08/08/19	CI
Spring Bank Pharmaceuticals, Inc. Appoints Pamela Klein as an Independent Member of its Board of Directors	10/07/19	CI
Madrigal Pharmaceuticals Announces Appointment of Jim Daly to Board of Directors	02/07/19	CI
Argenx SE Announces Executive Changes	22/05/19	CI
Bone Therapeutics Announces Appointment of Linda Lebon as Chief Regulatory Officer	29/10/18	CI
AC Immune SA Approves the Election of Werner Lanthaler to the Board of Directors	06/07/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders argenx SE Nasdaq

Equities

ARGX

US04016X1019

Insiders

Filters